Literature DB >> 21656527

Hedgehog signaling protein expression and its association with prognostic parameters in prostate cancer: a retrospective study from the view point of new 2010 anatomic stage/prognostic groups.

Tae-Jung Kim1, Ji Youl Lee, Tae-Kon Hwang, Chang Suk Kang, Yeong-Jin Choi.   

Abstract

BACKGROUND: The expression of Hedgehog (Hh) signaling pathway in prostate cancer is well-known but its clinicopathologic role has not been elucidated well.
METHODS: Prostatectomy cases of prostate cancer (n=155) were prepared and assessed by clinicopathologic parameters including new 2010 anatomic stage/prognostic groups (ASPG) of prostate cancer. The expression of five Hh signaling proteins including Sonic hedgehog (Shh), Patched, Smoothened, and GLIoma-associated oncogene, in addition with Suppressor of fused (Su(fu)) were analyzed immunohistochemically. Real-time polymerase chain reaction was performed to assess the mRNA expression status.
RESULTS: The expression of each Hh signaling protein was significantly correlated with poor prognostic parameters such as larger tumor size, high pretreatment prostate-specific antigen (PSA), high Gleason score, perineural invasion and new ASPG. Among Hh signaling proteins, Sonic hedgehog and Smoothened expressions tend to have a significantly higher risk of PSA recurrence (P<0.001 and P=0.011, respectively). Multivariate analysis proved Shh expression as independent prognostic factors of PSA recurrence along with Gleason score, ASPG, tumor volume, and pretreatment PSA.
CONCLUSIONS: Hh signaling activity is significantly associated with worse prognostic parameters. Shh can be regarded as a poor prognostic factor for PSA recurrence.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21656527     DOI: 10.1002/jso.21988

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  24 in total

Review 1.  Growth factor and signaling pathways and their relevance to prostate cancer therapeutics.

Authors:  Jocelyn L Wozney; Emmanuel S Antonarakis
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

2.  Aberrant sonic hedgehog signaling pathway and STAT3 activation in papillary thyroid cancer.

Authors:  Wenwu Dong; Junshuai Cui; Xinshuai Tian; Liang He; Zhihong Wang; Ping Zhang; Hao Zhang
Journal:  Int J Clin Exp Med       Date:  2014-07-15

3.  Inhibition of Gli1-mediated prostate cancer cell proliferation by inhibiting the mTOR/S6K1 signaling pathway.

Authors:  Hong Yang; Libing Hu; Zhimin Liu; Yang Qin; Ruiqian Li; Guoying Zhang; Bin Zhao; Chengwei Bi; Yonghong Lei; Yu Bai
Journal:  Oncol Lett       Date:  2017-10-23       Impact factor: 2.967

4.  Hedgehog signaling inhibition by the small molecule smoothened inhibitor GDC-0449 in the bone forming prostate cancer xenograft MDA PCa 118b.

Authors:  Maria Karlou; Jing-Fang Lu; Guanglin Wu; Sankar Maity; Vassiliki Tzelepi; Nora M Navone; Anh Hoang; Christopher J Logothetis; Eleni Efstathiou
Journal:  Prostate       Date:  2012-03-27       Impact factor: 4.104

5.  Elevated NF-κB/SHh/GLI1 Signature Denotes a Worse Prognosis and Represent a Novel Potential Therapeutic Target in Advanced Prostate Cancer.

Authors:  Davide Vecchiotti; Daniela Verzella; Mauro Di Vito Nolfi; Daniel D'Andrea; Irene Flati; Barbara Di Francesco; Jessica Cornice; Edoardo Alesse; Daria Capece; Francesca Zazzeroni
Journal:  Cells       Date:  2022-07-05       Impact factor: 7.666

6.  Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma.

Authors:  Chad M McKee; Danmei Xu; Yunhong Cao; Sheheryar Kabraji; Danny Allen; Veerle Kersemans; John Beech; Sean Smart; Freddie Hamdy; Adrian Ishkanian; Jenna Sykes; Melania Pintile; Michael Milosevic; Theodorus van der Kwast; Gaetano Zafarana; Varune Rohan Ramnarine; Igor Jurisica; Chad Mallof; Wan Lam; Robert G Bristow; Ruth J Muschel
Journal:  J Clin Invest       Date:  2012-10-08       Impact factor: 14.808

7.  The sonic hedgehog signaling pathway contributes to the development of salivary gland neoplasms regardless of perineural infiltration.

Authors:  Manuela Torres Andion Vidal; Sílvia Vanessa Lourenço; Fernando Augusto Soares; Clarissa Araújo Gurgel; Eduardo J B Studart; Ludmila de Faro Valverde; Iguaracyra Barreto de Oliveira Araújo; Eduardo Antônio Gonçalves Ramos; Flávia Caló de Aquino Xavier; Jean Nunes Dos Santos
Journal:  Tumour Biol       Date:  2016-01-21

8.  Patched 1 Expression Correlates with Biochemical Relapse in High-Risk Prostate Cancer Patients.

Authors:  Annelies Gonnissen; Sofie Isebaert; Christiaan Perneel; Chad M McKee; Filip Van Utterbeeck; Evelyne Lerut; Clare Verrill; Richard J Bryant; Steven Joniau; Ruth J Muschel; Karin Haustermans
Journal:  Am J Pathol       Date:  2018-01-12       Impact factor: 4.307

9.  Minor salivary gland carcinoma: a review of 35 cases.

Authors:  Georg Haymerle; Sven Schneider; Luke Harris; Theresia Häupl; Christian Schopper; Johannes Pammer; Matthaeus Ch Grasl; Boban M Erovic
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-10-23       Impact factor: 2.503

Review 10.  Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened.

Authors:  Annelies Gonnissen; Sofie Isebaert; Karin Haustermans
Journal:  Oncotarget       Date:  2015-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.